AxoGen (AXGN)
(Delayed Data from NSDQ)
$14.08 USD
-0.59 (-4.02%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $14.09 +0.01 (0.07%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
AxoGen (AXGN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$15.50 | $20.00 | $12.00 | 5.66% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for AxoGen comes to $15.50. The forecasts range from a low of $12.00 to a high of $20.00. The average price target represents an increase of 5.66% from the last closing price of $14.67.
Analyst Price Targets (6 )
Broker Rating
AxoGen currently has an average brokerage recommendation (ABR) of 1.17 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.17 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, five are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 83.33% and 16.67% of all recommendations. A month ago, Strong Buy made up 83.33%, while Buy represented 16.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.17 | 1.17 | 1.17 | 1.17 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/9/2024 | JMP Securities | David L Turkaly | Strong Buy | Strong Buy |
8/9/2024 | Cantor Fitzgerald & Co | Ross Osborn | Strong Buy | Strong Buy |
8/8/2024 | SVB Securities | Michael Kratky | Strong Buy | Strong Buy |
7/1/2024 | Raymond James | Jayson T Bedford | Not Available | Moderate Buy |
6/20/2024 | Canaccord Genuity | Caitlin Cronin | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.17 |
ABR (Last week) | 1.17 |
# of Recs in ABR | 6 |
Average Target Price | $15.50 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | 0.00 |
AXGN FAQs
AxoGen, Inc. (AXGN) currently has an average brokerage recommendation (ABR) of 1.17 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for AxoGen, Inc. (AXGN) is $15.50. The current on short-term price targets is based on 3 reports.
The forecasts for AxoGen, Inc. (AXGN) range from a low of $12 to a high of $20. The average price target represents a increase of $10.09 from the last closing price of $14.08.
The current UPSIDE for AxoGen, Inc. (AXGN) is 10.09%
Based on short-term price targets offered by six analysts, the average price target for AxoGen comes to $15.50. The forecasts range from a low of $12.00 to a high of $20.00. The average price target represents an increase of 5.66% from the last closing price of $14.67.